ライフサイエンスコーパス: cross-reactive

1 CMV epitopes, either conserved, variant, or cross-reactive.

2 are recognized by patient IgE and are highly cross-reactive.

3 n for the ability to be 'moderately' peptide cross-reactive.

4 ide binding, the ILA1 T-cell clone was still cross-reactive.

5 nigmatic: TCRs are at once specific but also cross-reactive.

6 bor intensive, and the resulting TCRs may be cross-reactive.

7 rtoire before vaccination revealed an Env-IM cross-reactive Ab that was clonally related to a subsequ

8 that neither the 2F5 bnAb nor HIV MPER-KYNU cross-reactive Abs elicited by immunization with an MPER

9 PV and three PV patients identified specific cross-reactive Abs in one PV patient, but notably all si

10 Such cross-reactive Abs may enhance disease during subsequent

11 o study the effects of these NS1-induced Plg cross-reactive Abs on fibrinolysis, we isolated several

12 results suggest that DENV NS1 can induce Plg cross-reactive Abs through molecular mimicry, which can

13 In previous studies, plasminogen (Plg) cross-reactive Abs, which can recognize DENV nonstructur

14 hila to determine whether NS1 can induce Plg cross-reactive Abs.

15 Six of these VHHs are cross-reactive against both EF and LF and recognize the

16 Anti-HA antibodies were cross-reactive against multiple subtypes, and some showe

17 ing the pIP501 plasmid and also proved to be cross-reactive against other clinically relevant enteroc

18 the first consumption of a food containing a cross-reactive allergen.

19 small number of amino acid differences among cross-reactive allergens can reduce the affinity of bind

20 ed to be termed 'fish-chicken syndrome' with cross-reactive allergens involved being parvalbumins, en

21 ry T cells can have high or low affinity for cross-reactive allogeneic peptide-MHC, the role of TCR a

22 Our data suggest that the cross-reactive anamnestic antibody response has a protec

23 The MAb footprints, cross reactive and strain specific, coincide with region

24 ization regimens for their ability to induce cross-reactive and biologically active V2 Abs in rabbits

25 The responses were robust and cross-reactive and contained antibodies specific to mult

26 In this study, we used cross-reactive and ferret-specific antibodies to study t

27 Anti-Flavivirus antibodies are highly cross-reactive and may facilitate Zika virus (ZIKV) infe

28 This work provides detailed insight into the cross-reactive and specific allergen-Ab interactions in

29 les to estimate the contribution of serotype-cross-reactive and type-specific antibodies to neutraliz

30 against E protein domain I/II (EDI/II) were cross-reactive and, although poorly neutralizing, potent

31 lated flaviviruses has long been known to be cross-reactive, and antibody detection of ZIKV is nonspe

32 We selected a high-affinity monkey cross-reactive anti-CLL-1 arm and tested several anti-CD

33 duction of polyreactive mutated IgA Abs with cross-reactive anti-commensal reactivity.

34 llenge in dengue vaccine development is that cross-reactive anti-DENV Abs can be protective or potent

35 Cross-reactive anti-MMR sdAbs were generated after immun

36 Abs on fibrinolysis, we isolated several Plg cross-reactive anti-NS1 mAbs from these mice and found t

37 t regimen, resulting in a high proportion of cross-reactive antibodies (25%).

38 into dengue virus (DENV) endemic regions and cross-reactive antibodies (Abs) could potentially affect

39 er was based on a virus that elicits broadly cross-reactive antibodies against a wide range of H5 vir

40 1 glycoconjugate resulted in high titers of cross-reactive antibodies against CR-Kp CPS in mice and

41 er present novel concepts for combination of cross-reactive antibodies against multiple epitopes that

42 ccination with related viruses and thus have cross-reactive antibodies against the vaccines.

43 etting the concern of ZIKV vaccines inducing cross-reactive antibodies and sensitizing people to subs

44 dinally within donors, suggesting that these cross-reactive antibodies are unstable.

45 This reduced shedding was associated with cross-reactive antibodies capable of mediating antibody-

46 Ad5 vaccine induced dominant gp41-microbiota cross-reactive antibodies derived from blood memory B ce

47 ease suggests that non-neutralizing serotype cross-reactive antibodies generated during a primary inf

48 Whether and how these cross-reactive antibodies impact live attenuated vaccina

49 solution allows similar proteins detected by cross-reactive antibodies in a single track.

50 envelope proteins raise the possibility that cross-reactive antibodies induced following Zika virus i

51 Thus, the gp41 commensal bacterial antigen cross-reactive antibodies originate in the intestine, an

52 Enhancing titres of cross-reactive antibodies prolonged YF vaccine viraemia,

53 Recombinant versions of these H1 + H3 cross-reactive antibodies showed broad binding to hemagg

54 The identification of cross-reactive antibodies that bind the GPs of all known

55 e and ferrets with H1-SS-np elicited broadly cross-reactive antibodies that completely protected mice

56 One group of cross-reactive antibodies that contributes considerably

57 ation with peptide 1 elicited high titers of cross-reactive antibodies to VEGF, with potent neutraliz

58 d sGP in complex with GP-specific and GP/sGP cross-reactive antibodies undergoing human clinical tria

59 findings support a pathogenesis model where cross-reactive antibodies wane from higher-titer, protec

60 Vaccines optimized to stimulate cross-reactive antibodies with ADCC function may provide

61 The latter, largely serotype-cross-reactive antibodies, demonstrated increased stabil

62 might continue to circulate, and to generate cross-reactive antibodies, particularly towards conserve

63 ine efficacy could be improved by exploiting cross-reactive antibodies.

64 nd DENV3 were mainly neutralized by serotype cross-reactive antibodies.

65 ing it from other structurally characterized cross-reactive antibodies.

66 nfection, HIV-1 can escape from even broadly cross-reactive antibodies.

67 infections and vaccinations may induce these cross-reactive antibodies.

68 Guinea pigs developed high titers of broadly cross-reactive antibodies; mice and ferrets exhibited na

69 immunoassay-like setting by capturing with a cross-reactive antibody (R109) binding to both proteins

70 Here, we examine the structural basis for cross-reactive antibody binding to RSV and HMPV F protei

71 ucture of Marburg virus GP in complex with a cross-reactive antibody from a human survivor, and a low

72 By evaluating the cross-reactive antibody response to the H10 viruses and

73 a on weight loss, viral replication, and the cross-reactive antibody response, we identified A/mallar

74 Anhui/1/2005 (clade 2.3.4) vaccine to elicit cross-reactive antibody responses to these emerging viru

75 Unexpectedly, Pca1 immunization generated cross-reactive antibody that recognized Pneumocystis jir

76 show that subjects with a specific range of cross-reactive antibody titres from a prior inactivated

77 h both an sGP-specific antibody and a GP/sGP cross-reactive antibody, permits us to unambiguously ass

78 hat older H3N2 influenza viruses confer some cross-reactive antibody.

79 tis surface protein, designated Pneumocystis cross-reactive antigen 1 (Pca1), as a potential vaccine

80 tients were more likely to seroconvert for a cross-reactive antigen if they seroconverted for the spe

81 at is impacted by the presence or absence of cross-reactive antigens in the patient's phenotype.

82 ture and epitopes in common were found using cross-reactive antisera.

83 high discrimination capacity of this type of cross-reactive array are ideal qualities for the develop

84 Sensitization to the cross-reactive Ascaris and mite tropomyosins partially u

85 xed chimerism can mediate thymic deletion of cross-reactive autoreactive T cells that express more th

86 ss II in mixed chimeras mediates deletion of cross-reactive autoreactive thymocytes.

87 the phenotype of DENV serotype-specific and cross-reactive B cells during and after natural DENV inf

88 DENV serotype-specific and cross-reactive B cells were identified in PBMCs from all

89 -class sequences were recovered from >40% of cross-reactive B cells.

90 R-HPVs, including finding 3 broadly antibody cross-reactive BCEs of L1 that each covers almost all HR

91 mmunodominant CD8 T cell response apparently cross-reactive between a newly defined putative MCMV epi

92 to other Env epitopes, (ii) displayed broad cross-reactive binding activity with gp120s and the V1V2

93 GII.4 cross-reactive blockade Ab titers were more potent than

94 ls of 50 and 100 Envs either to characterize cross-reactive breadth for sera identified as having pot

95 ned to elicit immune responses with improved cross-reactive breadth, to attempt to overcome the chall

96 sort for cells that are recognized by trimer cross-reactive broadly neutralizing antibody (bnAb) and

97 Inducing cross-reactive broadly neutralizing antibody (bNAb) resp

98 nding patches, explaining its role as both a cross-reactive but cytokine-specific receptor.

99 rity during secondary DENV infection is that cross-reactive but non-neutralizing antibodies promote u

100 Anti-FLE antibodies are broadly cross-reactive but poorly neutralizing, displaying a str

101 Several MTB candidate vaccine antigens were cross-reactive, but others were MTB-specific.

102 re excluded from the study because they were cross-reactive carbohydrate determinant reactors.

103 IgE reactivity to 6 HBV allergens devoid of cross-reactive carbohydrate determinants (CCD) was analy

104 Cross-reactive carbohydrate determinants (CCDs) in plant

105 ever, 48% of the African patients had IgE to cross-reactive carbohydrate determinants (CCDs) with low

106 As IgE glyco-epitopes, also referred to as cross-reactive carbohydrate determinants (CCDs), can sha

107 f different natural allergens, the so-called cross-reactive carbohydrate determinants (CCDs).

108 zed for IgE against 7 hazelnut allergens and cross-reactive carbohydrate determinants by ImmunoCAP.

109 glycan N-glycolylneuraminic acid or against cross-reactive carbohydrate determinants from plant or v

110 eteen recombinant wheat flour proteins and 2 cross-reactive carbohydrate determinants were tested by

111 epeated annual influenza vaccination on both cross-reactive CD4+ and CD8+ T cells has not been explor

112 Our data show that cross-reactive CD8 T cells are infrequent during the acu

113 Mono- and cross-reactive CD8 T cells use distinct TCRB CDR3 sequen

114 ZIKV/DENV cross-reactive CD8(+) T cells in DENV-immune mice expand

115 without compromising the induction of robust cross-reactive CD8+ T cell responses upon exposure to vi

116 homologous H1N1 2009 virus, failed to mount cross-reactive CD8+ T cells and succumbed to the second

117 A cross-reactive chemical sensing array was made from CdSe

118 ochondrial autoantigen of PBC and xenobiotic cross reactive chemicals.

119 ay even favor the expansion and dominance of cross-reactive clones, but only when conflicting selecti

120 e Abs in one PV patient, but notably all six cross-reactive clonotypes used VH1-46.

121 rom two PV patients identified no additional cross-reactive clonotypes.

122 Although some cross-reactive dengue virus (DENV)-specific antibodies c

123 ctionalizing the paper platform with diverse cross-reactive dyes sensitive to NH3 and CO2, their sele

124 higella, as well as ubiquitin/ubiquitin-like cross-reactive enzymes in Chlamydia, Rickettsia, and Xan

125 dominant response to a normally subdominant, cross-reactive epitope (nucleoprotein residues 205 to 21

126 antigenic epitopes on the HBoV1 capsid and a cross-reactive epitope on the HBoV1, HBoV2, and HBoV4 ca

127 ith cockroach allergen, we observed that non-cross-reactive epitope predominantly determined IgE bind

128 For clones that recognized the cross-reactive epitope, T cell clones responded robustly

129 results identify ZIKV-specific and ZIKV/DENV cross-reactive epitopes and demonstrate both an altered

130 rall, we define 13 novel CD4 and CD8 HSV-VZV cross-reactive epitopes and strongly imply additional cr

131 vaccinations for related pathogens and that cross-reactive epitopes and TCRs may be useful for multi

132 Cross-reactive epitopes bind with higher affinity to alp

133 ion of mice with ZIKV-specific and ZIKV/DENV cross-reactive epitopes elicited CD8(+) T cell responses

134 First, the T cells elicited by MTB/NTM cross-reactive epitopes in HCs were found mainly in a CC

135 Discovery of cross-reactive epitopes is critical to moving vaccine ca

136 C-terminal region of DENV NS1 in which host-cross-reactive epitopes reside.

137 , which were either cashew unique epitope or cross-reactive epitopes.

138 proteins can harbor both CD4 and CD8 HSV/VZV cross-reactive epitopes.

139 Several T-cell clones were cross-reactive, especially clones that recognized epitop

140 The cross-reactive EV71-specific ASC response to genogroup C

141 cells against NS1 or E proteins were poorly cross-reactive, even in donors preexposed to DENV.

142 Equally cross-reactive Fc receptor-mediated functional activitie

143 , the present work describes multiple novel, cross-reactive filovirus epitopes and innovative combina

144 et v 1, the major birch pollen allergen, its cross-reactive food allergens, and profilins.

145 Fish and chicken meat are cross-reactive foods; both fish-allergic and chicken mea

146 inity screening, but only 2 were found to be cross-reactive for human and mouse MMR.

147 neutralizing antibody specificities that are cross-reactive for VACV, CPXV, MPXV, and VARV and that a

148 trates for CB6 click that do not contain any cross-reactive functional groups and by optimizing react

149 ope binding affinities were mapped for human cross-reactive GAS proteins, including M5 and M6.

150 PV and 38.37% (95% CI = 12.68-56.51) against cross-reactive genotypes (HPV 31, 33, 45), respectively.

151 mediate potent secondary responses against a cross-reactive graft challenge.

152 gen Phl p 1 belongs to the group 1 of highly cross-reactive grass pollen allergens with a molecular m

153 imothy grass pollen allergen, belongs to the cross-reactive group 1 grass pollen allergens that are t

154 The impact of cross-reactive group matching and production of antibodi

155 s directionality in the protective effect of cross-reactive group matching.

156 e avian influenza virus H5N1 induced broadly cross-reactive HA stem-specific antibodies.

157 inct sH1N1 isolates in spite of preexisting, cross-reactive, HA-specific antibody titers.

158 Importantly, higher cross-reactive haemagglutination-inhibition antibody tit

159 influenza vaccine trials, we assessed their cross-reactive hemagglutination inhibition (HAI) antibod

160 is unknown whether there will be sufficient cross-reactive hemagglutinin (HA)-specific CD4 T-cell me

161 ogous prime-boost vaccination induced modest cross-reactive HI antibody responses to H5Nx viruses.

162 hat breaching peripheral tolerance permits a cross-reactive HIV-1 autoantibody response able to neutr

163 +) T cells from DENV-infected mice, and five cross-reactive HLA-B*0702-binding peptides were identifi

164 of molecular similarity among allergens and cross-reactive homologous helminth proteins in IgE-based

165 cts of clinical reagents, testing of species cross-reactive human agents in large animal GVHD models

166 SA inhibition results showing that, although cross-reactive human IgE epitopes exist, there are uniqu

167 erior to full-length HA antigens at inducing cross-reactive humoral immune responses and that VSV-cHA

168 3A mutations triggered cellular immunity and cross-reactive humoral immune responses.

169 sed by Bet v 1-specific IgE, but presence of cross-reactive IgE to related allergens does not predict

170 munization of mice and rabbits, MBC4 induced cross-reactive IgG antibodies, which were able to block

171 ine may have the added benefit of inducing a cross-reactive immune response to viral strains not foun

172 anasal route in addition to provoking higher cross-reactive immune responses against OMPs isolated fr

173 serotype-specific and strongly neutralizing cross-reactive immune responses against the four DENV se

174 sess the magnitude and functional quality of cross-reactive immune responses between these closely re

175 The cross-reactive immune responses frequently align with em

176 se data demonstrate that M type-specific and cross-reactive immune responses occur following skin inf

177 atients, we dissected ZIKV-specific and DENV-cross-reactive immune responses.

178 commercial CIV H3N8 IIV but provided limited cross-reactive immunity and heterologous protection agai

179 ld-type C57BL/6 mice infected with ZIKV have cross-reactive immunity to subsequent ZIKV infection and

180 multiple amphibian species, possibly through cross-reactive immunity.

181 al value, these nAbs must be both potent and cross-reactive in order to be capable of preventing the

182 modestly in magnitude and remained serotype cross-reactive in the years between infections, possibly

183 Cross-reactive influenza virus-specific antibody-depende

184 IgE stimulated by a cross-reactive inhalant allergen can result in diverse p

185 were highly variable, numerous instances of cross-reactive killing were observed.

186 Serology is cross-reactive, laborious, and frequently difficult to i

187 antileukemia immune responses by converting cross-reactive leukemia-specific T cells into Treg cells

188 Der p 1-specific mAbs 5H8 and 10B9, and the cross-reactive mAb 4C1.

189 e previously reported epitope for mAb 4C1, a cross-reactive mAb that binds Der p 1 and its homolog De

190 multiple ebolaviruses, including SUDV, and a cross-reactive mAb that completely protected guinea pigs

191 in V gene Abs generated according to mutated cross-reactive mAbs preserved their reactivity to both A

192 Cross-reactive MBCs were detected before vaccination and

193 uenza vaccine trial, we sorted hemagglutinin cross-reactive memory B cells and identified three antib

194 In mice with dominant cross-reactive memory responses, during challenge with P

195 both high-quality neoantigens and predicted cross-reactive microbial epitopes, consistent with neoan

196 Anti-MMR 3.49 was denoted as the lead cross-reactive MMR-targeting sdAb.

197 antibodies, specifically the two identified cross-reactive monoclonal antibodies (KL-2E5 and KL-2H7)

198 Human myosin cross-reactive N-terminal and B repeat epitopes of GAS M

199 The trimer also consistently induced cross-reactive NAbs against more sensitive (tier 1) viru

200 e demonstrate that the titer of preinfection cross-reactive NAbs correlates with reduced likelihood o

201 d to characterize the potency and breadth of cross-reactive neutralization by monoclonal antibodies,

202 demonstrate that immunized rabbits generated cross-reactive neutralizing activities against >50% of t

203 improve vaccine-induced responses, including cross-reactive neutralizing activities.

204 Efforts to elicit broadly cross-reactive neutralizing antibodies that will protect

205 Cross-reactive neutralizing antibodies to the RSV and HM

206 The induction of similar cross-reactive neutralizing antibodies using structural

207 In preimmune subjects, CYD-TDV boosted cross-reactive neutralizing antibodies while maintaining

208 nd characterized a panel of vaccine-elicited cross-reactive neutralizing MAbs targeting the Env V3 lo

209 allograft showed a dynamic expansion of the cross-reactive NLV-specific TCR repertoire before CMV re

210 to our knowledge, of the same A2-restricted cross-reactive NLV-specific TCR-alpha/beta signature (TR

211 Further, the broadly cross-reactive non-neutralizing antibodies generated in

212 pathology was directly associated with these cross-reactive NP205-specific CD8 memory cells.

213 use human-reactive reagents may not be fully cross-reactive or effective in vivo on NHP immune cells,

214 ctive epitopes and strongly imply additional cross-reactive peptide sets.

215 Here we isolated cross-reactive peptides with limited homology, which all

216 safety risk as they may respond optimally to cross-reactive peptides.

217 in children as well as to aeroallergens and cross-reactive plant allergen components in adults.

218 The cross-reactive plasmablast response to heterovariant str

219 ains, as indicated by the relative levels of cross-reactive plasmablasts and the cross-reactive PPAb

220 vaccination were evaluated for induction of cross-reactive plasmablasts, memory B cells, and cytokin

221 hl p 7 from timothy grass pollen is a highly cross-reactive pollen pan-allergen that can induce sever

222 ic infections with more severe symptoms, and cross-reactive, poorly neutralizing antibodies have been

223 evels of cross-reactive plasmablasts and the cross-reactive PPAb binding reactivity, was also greater

224 n significantly reduced vaccine-specific and cross-reactive PPAb responses.

225 Our study demonstrated that cross-reactive primary virus neutralizing B cell lineage

226 T-cells with various degrees of cross-reactive profiles could be detected.

227 n about whether or not antibodies can confer cross-reactive protection against viruses belonging to d

228 avian influenza (H5N1) virus elicits robust, cross-reactive protection from influenza virus infection

229 While broadly cross-reactive, protective monoclonal antibodies against

230 onents and phylogenetically highly conserved cross-reactive proteins.

231 tested the protective value of the serotype-cross-reactive "recall" or "anamnestic" response.

232 m MCMV-immune mice mount a robust CD8 T cell cross-reactive response between a newly defined putative

233 hould incorporate variant peptides to elicit cross-reactive responses against other specificities, es

234 f fHbp in N. cinerea and N. meningitidis and cross-reactive responses elicited by Bexsero suggest tha

235 Moreover, in the uncommon instances where cross-reactive responses were detected, the variant epit

236 t be, at least in part, set by the number of cross-reactive self peptides encountered by T cells duri

237 road spectrum, which provides a platform for cross-reactive sensitivity and allows detection of CO2 a

238 stitute a potential new source of primary or cross-reactive sensitization to lupin, particularly to L

239 analogous 2D MOFs can be used to construct a cross-reactive sensor array that allows for clear discri

240 e responses to highly penetrant viruses with cross-reactive serotypes.

241 tudy, we demonstrated the use of an array of cross-reactive serum albumins and fluorescent indicators

242 ive at generating HA stalk-specific, broadly cross-reactive serum antibodies by both intramuscular an

243 SV-cHAs generates greater stalk-specific and cross-reactive serum antibodies than does vaccination wi

244 ka virus infection induced detectable Dengue cross-reactive serum IgG responses that significantly am

245 developed significantly enhanced clade 2 H5 cross-reactive T cell responses detectable 6 months afte

246 In the absence of neutralizing antibodies, cross-reactive T cells have been shown to limit disease

247 oof of concept that LAIVs boost preexisting, cross-reactive T cells in children to genetically divers

248 at in the absence of neutralizing antibodies cross-reactive T cells provide protection against pandem

249 unity to related flaviviruses could generate cross-reactive T cells that may affect immune responses

250 We sought to demonstrate that cross-reactive T cells that recognize conserved epitopes

251 Preexisting cross-reactive T cells to genetically diverse IAV strain

252 A diverse array of TCRs was expressed by the cross-reactive T cells, with variable functional avidity

253 ory cells in healthy control subjects may be cross-reactive T cells.

254 by giving a competitive advantage to peptide cross-reactive T cells.

255 We studied the long-term cross-reactive T-cell response in 14 trivalent LAIV-vacc

256 derived from syngeneic sarcomas could induce cross-reactive T-cell responses and cross-protection aga

257 LAIV boosts durable, cross-reactive T-cell responses in children and may have

258 pratense, as well as their ability to induce cross-reactive T-cell responses.

259 .5 but not NOD.Rag1(-/-).BDC2.5 mice possess cross-reactive TCRs with endogenous TCRalpha-chains; MHC

260 to be more sensitive to activation and more cross-reactive than conventional T cells.

261 ) responses, as well as weak and/or sporadic cross-reactive tier 2 virus NAb responses with unknown s

262 elineate the specificity of vaccine-elicited cross-reactive tier 2 virus NAb responses, we performed

263 3-specific MAbs, nearly 20% (6/33) displayed cross-reactive tier 2 virus neutralization, which recapi

264 , suggesting that CP8-CRM elicits antibodies cross-reactive to CP5.

265 producing >/=2 cytokines simultaneously, and cross-reactive to NS proteins of the other 3 DENV seroty

266 These Abs were not cross-reactive to other self-MHC class I alleles display

267 The M protein was highly cross-reactive to TGEV and PRCV antisera.

268 el bispecific antibodies (Bis-mAbs) that are cross-reactive toward base epitopes on GP from EBOV and

269 antibodies have the potential to be broadly cross-reactive towards different HA subtypes.

270 ed chimerism mediates thymic deletion of the cross-reactive transgenic T cells in NOD.Rag1(+/+).BDC2.

271 , we demonstrate that thymic deletion of the cross-reactive transgenic T cells is dependent on MHC-mi

272 nstrate that NOD.Rag1(+/+).BDC2.5 BM-derived cross-reactive transgenic T cells, but not NOD.Rag1(-/-)

273 but not NOD.Rag1(-/-).BDC2.5 BM-derived non-cross-reactive transgenic T cells, can be positively sel

274 h sensitization to the highly allergenic and cross-reactive tropomyosins Asc l 3, Blo t 10 and Der p1

275 ology were observed between selected macaque cross-reactive V3 NAbs elicited by vaccination and proto

276 Striking similarities between the cross-reactive V3 NAbs elicited by vaccination in macaqu

277 ertheless, functional testing identified two cross-reactive VH1-46 Abs that both disrupt keratinocyte

278 The cross-reactive VHHs block binding of EF/LF to the protec

279 cephalitis NS1, a homologous and potentially cross-reactive viral antigen.

280 fic T-cell immunity followed by emergence of cross-reactive virus-specific T-cells.

281 Fish and chicken meat allergens were highly cross-reactive while high inhibition rates with fish or

282 es and found that the synbodies were broadly cross-reactive with affinities that ranged from 0.5 to 8

283 n, we saw that BCR-ABL-specific T cells were cross-reactive with an endogenous peptide derived from A

284 MSB0010853 is cross-reactive with HER3 and albumin of mouse origin.

285 DENV nonstructural protein 1 (NS1) which are cross-reactive with host Ags and trigger anti-DENV NS1 A

286 ra and that most of the antibody to HRV-C is cross-reactive with HRV-A.

287 ein, we identified a single peptide that was cross-reactive with human sera positive for either virus

288 Reagents from humans are usually cross-reactive with macaques, further facilitating the u

289 group matching and production of antibodies cross-reactive with mismatched antigens were also assess

290 FM15-35 Although NFM15-35 is immunogenic and cross-reactive with MOG at the polyclonal level, it fail

291 e we describe a set of monoclonal antibodies cross-reactive with multiple filovirus species.

292 of that peptide to trigger T cells that were cross-reactive with other non-P pratense pollen extracts

293 manized Fab' Ab fragment against human CD28, cross-reactive with rhesus monkey CD28.

294 The 19 mammalian Wnt proteins are cross-reactive with the 10 FZD receptors, and this has c

295 cities when the patient possessed an antigen cross-reactive with the donor mismatch, but the magnitud

296 gp41 membrane proximal region (MPER) and is cross-reactive with the HIV broadly neutralizing Ab (bnA

297 from SAM(H1-Cal)-immunized animals were not cross-reactive with the PR8 virus, whereas cross-reactiv

298 The vaccine-induced antibodies were broadly cross-reactive with the V1V2 regions of HIV subtypes B,

299 -affinity antibacterial (e.g., Yersinia) Abs cross-reactive with TSHR, eventually leading to TSAbs.

300 All of the sera tested were cross-reactive with ZIKV, both in binding and in neutral